Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 4/5
Cipla Ltd

Cipla Ltd (CIPLA IN)

164
Analysis
Health CareIndia
Cipla Limited manufactures and sells pharmaceutical and personal care products. The Company offers active pharmaceutical ingredients, and formulations in therapeutic areas, such as allergy, analgesic, anti malarial, anti-infectives, cardiology, dermatology and cosmeceuticals, diabetology, gastroenterology, steroids, iron chelators, nutritional products.
more
bullishCipla Ltd
11 May 2025 23:20

India: Potential Free Float Changes & Passive Flows in 3 Weeks

Changes to shareholding patterns could lead to changes in float for some stocks in local/global indices. Passive trackers will need to trade over 3...

Logo
346 Views
Share
bullishCipla Ltd
29 Jan 2025 22:35Broker

CIPLA Ltd - CIPLA Delivers Despite U.S. Struggles

The company’s US revenue stood at $226 Mn, reflecting a 1.7% YoY decrease, although this was affected by lower Lanreotide supply issues.

Logo
229 Views
Share
11 Mar 2024 13:23

Top APAC (Ex-China) Investment Worthy Healthcare Companies Using Smartkarma’s Smart Score Screener

We have screened APAC (ex-China) healthcare companies with market cap≥$800M using Smartkarma’s Smart Score and picked up 2 investable ideas by...

Logo
406 Views
Share
bullishCipla Ltd
29 Jul 2023 09:34

2023 High Conviction Update: Cipla (CIPLA IN)- Stellar Q1FY24 Performance; Margin Guidance Raised

Q1FY24 result beat expectations. Both India and the U.S. businesses reported record high revenue. EBITDA rose to multi-quarter high. For FY24,...

Logo
500 Views
Share
bullishCipla Ltd
02 Nov 2024 03:03Broker

Cipla Ltd - Meaningful New Launches to Drive Growth

Sharekhan's research report onCipla Cipla’s revenue reached Rs. 7,051 crore, reflecting a 7% y-o-y increase and a 6% q-o-q rise, meeting our...

Logo
Sharekhan
400 Views
Share
x